Phlexglobal Launches Career Development Training Curriculum
Phlexglobal has launched a new training curriculum for CRAs, CTAs, and document managers which addresses the growing requirement for a branded mix of knowledge and skills across the roles.
The new training curriculum was established to help meet Good Clinical (Research) Practice legislation on research.
European Head of Training at Phlexglobal, Dr. Gareth Hayes, explained: "The emphasis has been on quantity and speed rather than quality and effectiveness. This has been recognized by the authorities with audit and inspection findings constantly identifying inappropriately placed personnel whose roles outstretch their capabilities."
"Transferable skills are essential behavioural components that Phlexglobal recognizes as crucial in order to satisfy the demands of the job, whether as a CRA, CTA, or document manager. They are highly marketable because they are needed for a wide variety of jobs and can be transferred from one task, job, or workplace to another."
Phlexglobal is a specialist global CRO which delivers clinical research support solutions to meet its clients’ needs through its five core services of resourcing, task force, clinical support services, eTMF, and document solution and training. It works across the pharmaceutical, biotechnology, medical device, CRO and healthcare industries.
The three core groups, focus on people skills, practical skills, and adaptability skills, and combine with role-specific GCP training (from site responsibilities to TMF architecture).
All Phlexglobal’s training can be either delivered at its headquarters in Amersham or in-house at the client’s office.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
FDA Grants Ziftomenib with Breakthrough Therapy Designation for NPM1-Mutant Acute Myeloid Leukemia
April 23rd 2024Data from the Phase Ib portion of the KOMET-001 trial showed that the once-daily oral treatment may provide a substantial improvement over available therapies for relapsed/refractory NPM1-mutant acute myeloid leukemia.
